EQUELS THOMAS K (Exec. Vice Chairman/CEO/Pres.) purchased 2.8% of their position (50K shares) of AIM IMMUNOTECH INC. on the open market
Open‑market purchase worth $6.7K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/6/2025ACC: 0001493152-25-009338
DirectorOfficer· Exec. Vice Chairman/CEO/Pres.
Since Jul 2018
+50K
Net shares
Net buyer
$6.7K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50K
Price / share
$0.13
Trade value
$6.73K
% of position
2.8%
3/5/2025
1.81M→1.86M
Total
Net shares
+50K
Net value
$6.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/5/2025 | P · Purchase | +50K | $0.13 | $6.73K | 2.8% | 1.81M | 1.86M |
| Total | +50K | $6.73K | ||||||
Derivative Transactions0
No derivative transactions reported